Saudi Arabia’s gastroenterology and endoscopy landscape is moving on two tracks at once: steady diagnostic demand and faster device-led modernization. Grand View Research estimates the Saudi Arabia gastrointestinal diagnostics market generated USD 33.5 million in revenue in 2024 and is expected to reach USD 37.8 million by 2030, with a 1.9% CAGR from 2025 to 2030. In that same diagnostics breakdown, endoscopy was the largest test type in 2024, holding a 29.25% revenue share. Those figures highlight how diagnostic workflows keep endoscopy central, even as spending expands unevenly across modalities and settings.
Device procurement tells a different growth story. Mordor Intelligence values the Saudi Arabia endoscopy devices market at USD 559.32 million in 2025, estimating growth from USD 589.86 million in 2026 to USD 769.54 million by 2031, at a 5.46% CAGR during 2026–2031. Within that market, endoscopes held 52.12% share in 2025. By end user, hospitals commanded 61.05% of the market size in 2025, while ambulatory surgery centers are projected to post the fastest 11.63% CAGR through 2031. The net effect is a purchasing mix that still favors hospitals, but increasingly rewards flexible capacity closer to outpatient demand.
What’s Driving Demand: Burden, Screening, and Smarter Visualization
Several signals point to why endoscopy remains a priority in Saudi care pathways. A pediatric clinics survey cited in the Saudi Journal of Gastroenterology found 47.7% of infants and toddlers in the Kingdom showed signs of functional gastrointestinal disorders, reinforcing the importance of structured evaluation from early life. The same source notes April 2024 research indicating nearly one-third of colorectal cancer patients across the Kingdom are diagnosed at late stages, a finding linked to stronger interest in organized screening programs and investment in next-generation endoscopic imaging. In parallel, Vision 2030 is referenced with a target to raise private healthcare expenditure from 25% to 35% of total healthcare spending, which is frequently framed as supportive of capital spending on advanced diagnostics.
Technology claims are increasingly tied to performance outcomes. A Saudi Journal of Gastroenterology highlight cited in April 2026 points to AI in endoscopy delivering 5–10% higher adenoma detection rates and over 80% faster capsule endoscopy processing. Market segmentation also reflects where equipment budgets may concentrate: Mordor Intelligence reports gastroenterology accounted for 39.06% of the Saudi Arabia endoscopy devices market size in 2025. Meanwhile, visualization equipment is forecast to expand at a 9.78% CAGR through 2031, suggesting that upgrades are not only about scopes but also about the imaging stack that interprets what clinicians see and how quickly they can act.
For broader context, global demand is rising too, but those numbers should not be read as Saudi-specific. Cognitive Market Research records the global gastrointestinal endoscopy market at $9,622.21 million in 2021, projecting $12,079.2 million by 2025 and $19,035.5 million by 2033, with a 5.85% CAGR during 2025–2033. Dimension Market Research separately projects Saudi Arabia’s gastroenterology market at USD 1.1 billion in 2026 and USD 2.0 billion by 2035, at a 7.4% CAGR. Taken together, these snapshots frame the Saudi gastroenterology market as one where endoscopy is both a diagnostic cornerstone and a procurement engine, shaped by screening urgency, hospital dominance, and faster-growing outpatient and visualization segments.
How large is Saudi Arabia’s gastrointestinal diagnostics market, and what is the outlook?
Which diagnostic test type led revenue share in Saudi GI diagnostics?
What is the size and growth outlook for Saudi Arabia’s endoscopy devices market?
How is care setting shifting between hospitals and ambulatory surgery centers?
What does current research suggest about momentum in the Saudi gastroenterology market?
